Quest Diagnostics and hc1 collaborate to optimize enterprise-wide laboratory testing for health systems

Staff - Print  | 

Quest Diagnostics and hc1 developed a new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization. 

 Editor's Note: This article originally appeared on Quest Diagnostic's website.  

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and hc1, the bioinformatics leader in precision testing, today unveiled Quest® Lab Stewardship™ powered by hc1®, an innovative new service that employs machine learning to harmonize laboratory testing across health systems in order to help optimize laboratory test utilization.* 

Quest Lab Stewardship is the result of a strategic collaboration between Quest and hc1 focused on improving costs and clinical impact of lab testing, in- and out- of hospital settings. 

"While lab testing is fundamental to delivering cost-effective healthcare, opportunities remain to drive out clinical variation when looking across patient touch points in a health system. Working with hc1, we've created a solution that overcomes several of the traditional barriers to delivering real-time enterprise insights needed to drive and support at-scale optimization of lab testing," said David Freeman, General Manager, Information Ventures, Quest Diagnostics. Click here to continue reading>> 

 

 

News from our Partner

 

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.